Vallon Pharmaceuticals, Inc. (VLON): Price and Financial Metrics
VLON Price/Volume Stats
| Current price | $12.00 | 52-week high | $12.92 |
| Prev. close | $0.46 | 52-week low | $0.21 |
| Day low | $11.41 | Volume | 37,113 |
| Day high | $12.92 | Avg. volume | 5,783,646 |
| 50-day MA | $0.47 | Dividend yield | N/A |
| 200-day MA | $0.38 | Market Cap | 161.78M |
VLON Stock Price Chart Interactive Chart >
Vallon Pharmaceuticals, Inc. (VLON) Company Bio
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
VLON Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -80.58% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -85.45% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...